The Wayback Machine - http://web.archive.org/web/20240826221254/https://finance.yahoo.com/sectors/healthcare/
Healthcare
This sector includes biotechnology, pharmaceuticals, research services, home healthcare, hospitals, long-term-care facilities, and medical equipment and supplies. Also include pharmaceutical retailers and companies which provide health information services. Companies in this sector include AstraZeneca, Pfizer, and Roche Holding, Walgreens Boots Alliance, and Cerner Corp.
Market Cap
7.079T
Market Weight
11.22%
Industries
11
Companies
1202
Healthcare S&P 500 ^GSPC
Loading Chart for Healthcare
DELL

Day Return

Sector
0.10%
S&P 500
0.32%

YTD Return

Sector
11.83%
S&P 500
17.76%

1-Year Return

Sector
14.81%
S&P 500
27.49%

3-Year Return

Sector
3.92%
S&P 500
24.92%

5-Year Return

Sector
77.95%
S&P 500
95.14%

Note: Sector performance is calculated based on the previous closing price of all sector constituents

Industries in This Sector

Select an Industry for a Visual Breakdown

IndustryMarket WeightYTD Return
All Industries
100.00%
11.83%
Drug Manufacturers - General
34.80%
20.51%
Healthcare Plans
13.47%
4.98%
Biotechnology
11.60%
5.75%
Medical Devices
11.52%
1.41%
Diagnostics & Research
11.16%
9.26%
Medical Instruments & Supplies
6.97%
17.73%
Medical Care Facilities
3.29%
35.69%
Drug Manufacturers - Specialty & Generic
2.72%
1.51%
Medical Distribution
2.21%
10.38%
Health Information Services
2.13%
17.09%
Pharmaceutical Retailers
0.13%
-59.73%

Note: Percentage % data on heatmap indicates Day Return

Largest Companies in This Sector

View More
Name
Last Price
1Y Target Est.
Market Weight
Market Cap
Day Change %
YTD Return
Avg. Analyst Rating
950.53 1,003.10 12.27% 855.882B -0.23% +63.06%
Buy
587.13 619.83 7.77% 542.166B +0.45% +11.52%
Buy
164.61 171.47 5.68% 396.256B +0.29% +5.02%
Buy
197.44 196.64 5.00% 348.746B -0.06% +27.41%
Buy
116.27 140.31 4.23% 294.722B -0.28% +6.65%
Buy
605.59 630.67 3.32% 231.333B -0.09% +14.09%
Buy
112.70 124.04 2.81% 196.087B +0.01% +2.39%
Buy
268.07 284.85 2.78% 193.604B -0.52% +15.88%
Buy
326.78 328.50 2.52% 175.588B -0.61% +13.46%
Buy
479.19 482.39 2.44% 170.282B -1.51% +42.04%
Buy

Investing in the Healthcare Sector

Start Investing in the Healthcare Sector Through These ETFs and Mutual Funds

ETF Opportunities

View More
Name
Last Price
Net Assets
Expense Ratio
YTD Return
155.37 40.661B 0.09% +13.92%
284.96 21.092B 0.10% +13.67%
147.88 7.976B 0.45% +8.86%
101.70 7.812B 0.35% +13.90%
57.96 4.88B 0.40% +7.39%

Mutual Fund Opportunities

View More
Name
Last Price
Net Assets
Expense Ratio
YTD Return
236.81 48.824B 0.30% +13.25%
99.87 48.824B 0.30% +13.27%
142.76 21.092B 0.10% +13.83%
102.22 15.167B 0.80% +16.00%
101.89 15.167B 0.80% +15.92%

Healthcare Research

View More

Discover the Latest Analyst and Technical Research for This Sector

  • Analyst Report: Tilray Brands, Inc.

    Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis. In 2021, legacy Aphria acquired legacy Tilray in a reverse merger and renamed itself Tilray. The bulk of its sales are in Canada and in the international medical cannabis export market. US exposure consists of CBD products and alcohol.

    Rating
    Price Target
     
  • Analyst Report: McKesson Corporation

    McKesson Corp is one of three leading pharmaceutical wholesalers in the US engaged in sourcing and distributing branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with Cencora and Cardinal Health, the three account for over 90% of the US pharmaceutical wholesale industry. Outside the US market, McKesson engages in pharmaceutical wholesale and distribution in Canada. Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.

    Rating
    Price Target
     
  • Weekly Stock List

    Vickers Stock Research, a subsidiary of Argus Research Group, analyzes insider trading and institutional stock ownership. Form 13Fs, which institutions must file to report their holdings, are due 45 days after the end of calendar quarters and have come in for 2Q24. We review 13Fs of major institutional investors, including activists, to see what they are buying and to look for trends. Activist investing is now less about generating a short-term return and more about achieving long-term returns through an active management/investor partnership. The stock-market volatility during 2Q gave those institutional investors a chance to buy a dip. Taking a look at the 13Fs from well-known institutional portfolios, we see that the big guns were busy, either adding new holdings or increasing existing holdings. Buying was across a variety of sectors. Based on Vickers data, the following are select purchases made in 2Q by some high-profile money managers. We also list one significant sale (of Apple by Berkshire) and also note if the holding is now 4% or more of the total portfolio.

     
  • Daily – Vickers Top Insider Picks for 08/26/2024

    The Vickers Top Insider Picks is a daily report that utilizes a proprietary algorithm to identify 25 companies with compelling insider purchase histories based on transactions over the past three months.

     

From the Community

Healthcare News